1. Engraftment Syndrome after Autologous Stem Cell Transplantation: An Update Unifying the Definition and Management Approach 
Robert Frank Cornell, Parameswaran Hari, William R. Drobyski 
Biology of Blood and Marrow Transplantation 
Volume 21, Issue 12, Pages (December 2015)
DOI: /j.bbmt
Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
Engraftment syndrome encompasses a spectrum of ASCT-associated syndromes that vary in degrees of severity. PERDS indicates periengraftment respiratory distress syndrome; CLS, capillary leak syndrome.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
Hypothetical mechanisms of ES. Proposed stages and severities of ES after ASCT are modeled. Predicted cytokine and leukocyte involvement is shown for each stage. Neutrophil and T cell engraftments are complete by days 14 and 56, respectively. TNF indicates tumor necrosis factor; Mac, macrophage; N, neutrophil; DC, dendritic cell; CD4, helper T cell; CD8, cytotoxic T cell; B, B cell; NE, normal epithelium.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions

4. Figure 3
Our management approach to ES. IST indicates immunosuppressive therapy.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions